Search research articles
Contact Us
Filters
Showing results (461-470 of 512) with videos related to
Page
of 52
Sort By:
The Journal of Biological Chemistry
|
October 11, 2012
Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease
Fredrik Jeppsson, Susanna Eketjäll, Juliette Janson, et al.
Psychopharmacology
|
May 2, 2000
Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's disease
K Nobuhara, C Halldin, H Hall, et al.
PLOS Global Public Health
|
November 21, 2024
Sex differences in alcohol use patterns and related harms: A mixed-methods, cross-sectional study of men and women in northern Tanzania
Madeline McNee, Niveditha Badrinarayanan, Eleanor Strand, et al.
BMC Psychiatry
|
March 18, 2022
Prevalence and perception of substance abuse and associated economic indicators and mental health disorders in a large cohort of Kenyan students: towards integrated public health approach and clinical management
Victoria N Mutiso, David M Ndetei, Esther N Muia, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 14, 2013
AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice
Susanna Eketjäll, Juliette Janson, Fredrik Jeppsson, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 18, 2013
Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients
Anton Forsberg, Anders Juréus, Zsolt Cselényi, et al.
Nuclear Medicine and Biology
|
June 10, 1998
Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling
S Osman, C Lundkvist, V W Pike, et al.
American Heart Journal
|
March 10, 2021
Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction: Sex-related outcomes from DETO2X-AMI
Joakim Alfredsson, Stefan K James, David Erlinge, et al.
European Journal of Nuclear Medicine
|
May 30, 1998
[carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo
V W Pike, C Halldin, J A McCarron, et al.
Lancet (London, England)
|
September 3, 2016
Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study
Lars Wallentin, Lars Lindhagen, Elisabet Ärnström, et al.
Page
of 52
Search research articles
Search
Showing results (461-470 of 512) with videos related to
Sort By:
Page
of 52
The Journal of Biological Chemistry
|
October 11, 2012
Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease
Fredrik Jeppsson, Susanna Eketjäll, Juliette Janson, et al.
Psychopharmacology
|
May 2, 2000
Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's disease
K Nobuhara, C Halldin, H Hall, et al.
PLOS Global Public Health
|
November 21, 2024
Sex differences in alcohol use patterns and related harms: A mixed-methods, cross-sectional study of men and women in northern Tanzania
Madeline McNee, Niveditha Badrinarayanan, Eleanor Strand, et al.
BMC Psychiatry
|
March 18, 2022
Prevalence and perception of substance abuse and associated economic indicators and mental health disorders in a large cohort of Kenyan students: towards integrated public health approach and clinical management
Victoria N Mutiso, David M Ndetei, Esther N Muia, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 14, 2013
AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice
Susanna Eketjäll, Juliette Janson, Fredrik Jeppsson, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 18, 2013
Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients
Anton Forsberg, Anders Juréus, Zsolt Cselényi, et al.
Nuclear Medicine and Biology
|
June 10, 1998
Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling
S Osman, C Lundkvist, V W Pike, et al.
American Heart Journal
|
March 10, 2021
Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction: Sex-related outcomes from DETO2X-AMI
Joakim Alfredsson, Stefan K James, David Erlinge, et al.
European Journal of Nuclear Medicine
|
May 30, 1998
[carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo
V W Pike, C Halldin, J A McCarron, et al.
Lancet (London, England)
|
September 3, 2016
Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study
Lars Wallentin, Lars Lindhagen, Elisabet Ärnström, et al.
Page
of 52